NCT04272502View on ClinicalTrials.gov

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 4, 2019

Primary Completion Date

August 26, 2019

Study Completion Date

August 26, 2019

Conditions
Healthy
Interventions
DRUG

CKD-348 F1, CKD-348 F2, CKD-828, D326, D337

Each arm has a different order for taking IP

Trial Locations (1)

Unknown

Seoul National University Bundang Hospital, Gyeonggi-do

Sponsors
All Listed Sponsors
collaborator

Seoul National University Bundang Hospital

OTHER

lead

Chong Kun Dang Pharmaceutical

INDUSTRY